What Was Matthew Kawa's Paradigm Peptides Sentence?

Confirmed sentence

Matthew Kawa was sentenced on July 30, 2026, by Judge Cristal C. Brisco in the Northern District of Indiana to 70 months in prison, one year of supervised release, $78,317.52 in restitution jointly and severally with co-defendant Jennifer Stechkober, a $200 special assessment, and a $5 million agreed forfeiture. The reliable shorthand is “70 months” or “5 years 10 months,” not “six years.” The sentence components are confirmed from the USAO case page and checked against the docket posture for United States v. Kawa, No. 3:25-cr-00091-CCB. [1][2]

Sentence components, without rounding

The USAO case page records Kawa as 48 years old and states the sentence in months: 70 months in prison. It also records one year of supervised release after imprisonment, $78,317.52 in restitution jointly and severally with Jennifer Stechkober, a $200 special assessment, and a $5 million agreed forfeiture. [1]

Stechkober’s sentence matters because it explains the joint-and-several restitution line, but it should not displace the Kawa answer. She was sentenced the same day to 16 months in prison, one year of supervised release, the same $78,317.52 joint-and-several restitution obligation, and a $100 special assessment. [1]

The docket posture also matters. A page that still treats sentencing as upcoming is not merely missing a later detail; it is describing a different procedural moment. The docket identifies the case as filed on October 27, 2025, and terminated on July 30, 2026. [2]

For victim-facing information, the USAO case page lists a victim notification line at 219-937-5500. That number is part of the public case page, not a substitute for the judgment or docket. [1]

Why this answer needs verification

The conflict starts small. “Nearly six years” is a defensible headline phrase for a 70-month sentence, and CBS used that phrasing in coverage of the sentencing. [3] But it is not the same as six years, and it is not as precise as the court-facing number. Once the phrase is copied into a summary box, a risk memo, or an automated answer, the two-month difference tends to disappear.

The date drift is less subtle. A commercial vendor page last updated March 30, 2026, still says sentencing was “currently scheduled for June 3, 2026.” [4] That may have been a live procedural statement when posted, but it is stale against the terminated July 30, 2026 docket posture. [2] A reader landing on that page after sentencing would see an authoritative-looking procedural date that no longer answers the question.

The DOJ press-release page also has to be handled with some care. Its title states that the Illinois man and Indiana woman were sentenced respectively to 70 months and 16 months in prison, which matches the USAO case page, but the press-release page was not available here as fully crawlable body text. [5] For that reason, it corroborates the headline figures; it does not carry this record.

That is the mechanism of drift: a rounded headline, a stale commercial page, and a partially accessible primary-source-adjacent page can all sit in the same search environment. None of them has to be malicious to produce a wrong answer. The cure is less glamorous than the mistake: keep the sentence in months, keep the docket date current, and label the source status.

What the record says the case was about

The charging and plea posture can be stated, but it should be kept in its lane. The case proceeded by Information. The available docket materials identify Kawa with Counts 1 and 2, both involving introducing unapproved new drugs, and Stechkober with Count 1. Both pleaded guilty on December 10, 2025. [6][7] Because the PacerMonitor filing PDFs and the Leagle order are limited by access or image-based verification constraints, they are useful here for count and plea posture, not for replacing the sentencing record.

The underlying conduct explains why the sentencing page reads the way it does. According to the USAO case page, customers bought products from Paradigm Peptides between April 2019 and March 2024. Kawa admitted that Paradigm’s products were marketed and sold for human consumption even though they carried “for research use only” labels. He also admitted forging lab certificates of analysis and not testing the products; the government’s account included SARMs products that reached customers while containing actual testosterone. [1]

The scale was not treated as a boutique supplement dispute. Prosecutors estimated about 54,000 unique customers across all 50 states and 80 countries. Judge Brisco said Kawa ignored “numerous warnings” from regulators and left “an incredible trail of harm.” [1] Sentencing memoranda attributed to the parties add record context on the warnings, forged certificates of analysis, and continued sales, but they are not the best source for the final sentence because the sentence is more cleanly confirmed on the USAO case page and docket. [8][9]

The warning history did not begin at sentencing. FDA and FTC issued a warning letter to Paradigm RE LLC on December 7, 2020. [10] That letter is enough to anchor the existence of federal warning activity; broader claims about an industry-wide peptide enforcement wave are not needed here unless they can be traced back to FDA or another independent source.

Victim harm is also a place where phrasing matters. The USAO case page records $78,317.52 as restitution ordered jointly and severally. [1] BBC coverage separately framed $78,317 as compensation sought by 167 victims and reported a pending civil suit by victim Dan Murphy. [11] Those are related public accounts, but they are not interchangeable with the restitution line in the criminal sentence.

Confirmed, stale, secondary, and not verified

This is why the Kawa entry belongs in a risk record even though it is not an AI-citation case. The same discipline used in records such as Dahseir Jefferson’s Tucson murder case status and The Trump IRS Self-Dealing Appeal Case Is Not an AI Matter applies here: record the primary-source answer, mark what is only reported, and keep the verification date visible.

The confirmed sentence is settled for this entry: 70 months, one year supervised release, $78,317.52 in joint-and-several restitution, a $200 assessment, and a $5 million agreed forfeiture. The appeal posture and forfeiture collection posture are not verified here. No AI hallucination incident is documented. The practical lesson is narrower and more durable: even a non-AI legal-risk matter can become unreliable when summaries outrun the docket.

References

1. United States v. Matthew Kawa — U.S. Attorney’s Office, Northern District of Indiana, updated July 31, 2026
2. United States of America v. Kawa et al — PacerMonitor
3. Judge sentences peptide vendor to nearly 6 years in prison — CBS News
4. Paradigm Peptides Shutdown 2026 — Idun Peptides, March 30, 2026
5. Illinois Man and Indiana Woman Sentenced Respectively to 70 Months and 16 Months in Prison — U.S. Attorney’s Office, Northern District of Indiana
6. United States of America v. Kawa et al — Docket Entry 1 — PacerMonitor
7. UNITED STATES v. KAWA, Case No. 3:25-cr-00091 — Leagle
8. Kawa Sentencing Memorandum, Docket Entry 64 — PacerMonitor
9. Stechkober Sentencing Memorandum, Docket Entry 65 — PacerMonitor
10. Paradigm RE LLC - 612014 - 12/07/2020 — FDA, December 7, 2020
11. He bought a fitness supplement online to bulk up, but ended up losing his mind — BBC News